Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(3-(2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl)methoxy)phenyl)-3-hydroxy-1-azetidinyl)isonicotinic Acid
2. 2-(3-(2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)phenyl)-3-hydroxyazetidin-1-yl)isonicotinic Acid
1. 1418274-28-8
2. Gs-9674
3. Cilofexor [inn]
4. Px104
5. Yun2306954
6. 2-[3-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]-3-hydroxyazetidin-1-yl]pyridine-4-carboxylic Acid
7. Gs 9674
8. 2-(3-(2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)phenyl)-3-hydroxyazetidin-1-yl)isonicotinic Acid
9. 2-(3-(2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)phenyl)-3-hydroxy-1-azetidinyl)-4-pyridinecarboxylic Acid
10. 2-[3-[4-[[3-[2,6-bis(chloranyl)phenyl]-5-cyclopropyl-1,2-oxazol-4-yl]methoxy]-2-chloranyl-phenyl]-3-oxidanyl-azetidin-1-yl]pyridine-4-carboxylic Acid
11. 4-pyridinecarboxylic Acid, 2-(3-(2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)phenyl)-3-hydroxy-1-azetidinyl)-
12. 2-[3-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl]methoxy]phenyl]-3-hydroxy-1-azetidinyl]-4-pyridinecarboxylic Acid
13. Cilofexor (gs(c)\9674)
14. Chembl4297613
15. Schembl14641986
16. Unii-yun2306954
17. Gtpl10644
18. Gs 9674 [who-dd]
19. Bcp29283
20. Bdbm50511109
21. Gs9674
22. S6547
23. Db15168
24. Ac-35893
25. Example 13/9 [us10485795b2]
26. Hy-109083
27. Cs-0039260
28. F78361
29. A927993
30. 2163097-55-8
| Molecular Weight | 586.8 g/mol |
|---|---|
| Molecular Formula | C28H22Cl3N3O5 |
| XLogP3 | 5.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 8 |
| Exact Mass | 585.062504 g/mol |
| Monoisotopic Mass | 585.062504 g/mol |
| Topological Polar Surface Area | 109 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 867 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of primary sclerosing cholangitis
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Cilofexor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cilofexor, including repackagers and relabelers. The FDA regulates Cilofexor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cilofexor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cilofexor supplier is an individual or a company that provides Cilofexor active pharmaceutical ingredient (API) or Cilofexor finished formulations upon request. The Cilofexor suppliers may include Cilofexor API manufacturers, exporters, distributors and traders.
Cilofexor Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cilofexor GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cilofexor GMP manufacturer or Cilofexor GMP API supplier for your needs.
A Cilofexor CoA (Certificate of Analysis) is a formal document that attests to Cilofexor's compliance with Cilofexor specifications and serves as a tool for batch-level quality control.
Cilofexor CoA mostly includes findings from lab analyses of a specific batch. For each Cilofexor CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cilofexor may be tested according to a variety of international standards, such as European Pharmacopoeia (Cilofexor EP), Cilofexor JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cilofexor USP).
LOOKING FOR A SUPPLIER?
